Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Michal, Droppa"'
Autor:
Jan Baan, Peter Bramlage, Niels-Erik Nielsen, Jana Kurucova, Tanja Rudolph, Michal Droppa, Jacek Baranowski, Violetta Hachaturyan, Luis Hack, Tobias Geisler
Publikováno v:
Open Heart, Vol 10, Iss 1 (2023)
Objective The onset of new conduction abnormalities requiring permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is still a relevant adverse event. The main objective of this registry was to identify modifiabl
Externí odkaz:
https://doaj.org/article/023299ca714841e2901ff20dd936fcfd
Publikováno v:
Case Reports in Cardiology, Vol 2023 (2023)
We present a case of a patient with a transient ischaemic attack (TIA) likely due to paradoxical embolism through a patent foramen ovale (PFO). Her medical history included 2nd-degree heart block Mobitz II, which manifested with recurrent syncopes an
Externí odkaz:
https://doaj.org/article/cb318ac266ec44c3a84ea20f7b59c5b4
Publikováno v:
Plants, Vol 11, Iss 23, p 3375 (2022)
The aim of the study was to analyse selected aspects of the natural variability of selected varieties of Vitis vinifera. Grapevine is one of the most popular and desirable crops in the world due to the great tradition of wine production, but grape ex
Externí odkaz:
https://doaj.org/article/cd7081b61efa4611abba2dfd36bf408c
Autor:
Michal Droppa, Monika Zdanyte, Jessica Kristin Henes, Meinrad Gawaz, Oliver Borst, Dominik Rath
Publikováno v:
Thrombosis Research. 226:33-35
Autor:
Oliver Borst, Patrick Münzer, Nada Alnaggar, Sascha Geue, Roland Tegtmeyer, Dominik Rath, Michal Droppa, Peter Seizer, Stefan Heitmeier, Johan W.M. Heemskerk, Lisa K. Jennings, Robert F. Storey, Dominick J. Angiolillo, Bianca Rocca, Henri Spronk, Hugo Ten Cate, Meinrad Gawaz, Tobias Geisler
Publikováno v:
Blood Advances, Vol 2, Iss 6, Pp 715-730 (2018)
Abstract: Very low–dose (VLD) factor Xa (FXa) inhibition, in combination with acetylsalicylic acid (ASA) and clopidogrel, is associated with improved outcomes in patients with acute coronary syndrome (ACS) with a tolerable bleeding risk profile. To
Externí odkaz:
https://doaj.org/article/d9e3884a70ea426791e0641813794a24
Autor:
Michal Droppa, Oliver Borst, Dominik Rath, Karin Müller, Meinrad Gawaz, Deepak L. Bhatt, Tobia Geisler
Publikováno v:
Cellular Physiology and Biochemistry, Vol 42, Iss 4, Pp 1336-1341 (2017)
Background/Aims: Patients with acute coronary syndromes (ACS) presenting with cardiogenic shock (CS) are at particular risk for death and adverse cardiac events. Impaired effects and absorption of oral P2Y12-receptor inhibitors due to decreased organ
Externí odkaz:
https://doaj.org/article/fa7246727f2d44289ff7feda897287fb
Autor:
Dominik Rath, Madhumita Chatterjee, Angela Bongartz, Karin Müller, Michal Droppa, Fabian Stimpfle, Oliver Borst, Christine Zuern, Sebastian Vogel, Meinrad Gawaz, Tobias Geisler
Publikováno v:
Platelets, Vol 28, Iss 1, Pp 34-39 (2017)
Platelet surface expression levels of stromal cell derived factor 1 (SDF-1) are elevated in acute coronary syndrome and associated with LVEF% improvement after myocardial infarction (MI). Platelet SDF-1 might facilitate thrombus formation and endomyo
Externí odkaz:
https://doaj.org/article/069f85185eec4390b98c52c4204b09aa
Autor:
Tanja Rudolph, Michal Droppa, Jan Baan, Niels-Erik Nielsen, Jacek Baranowski, Violetta Hachaturyan, Jana Kurucova, Luis Hack, Peter Bramlage, Tobias Geisler
Publikováno v:
Open heart, 10(1):e002191. BMJ Publishing Group
ObjectiveThe onset of new conduction abnormalities requiring permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is still a relevant adverse event. The main objective of this registry was to identify modifiable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64f60c7bc7b44a6dba403ea9b55a68fe
https://pure.amc.nl/en/publications/modifiable-risk-factors-for-permanent-pacemaker-after-transcatheter-aortic-valve-implantation(8b919c2f-f200-4c89-9666-3bf43aef7dc8).html
https://pure.amc.nl/en/publications/modifiable-risk-factors-for-permanent-pacemaker-after-transcatheter-aortic-valve-implantation(8b919c2f-f200-4c89-9666-3bf43aef7dc8).html
Autor:
Johannes Patzelt, Miriam Ulrich, Annika Becker, Karin A L Müller, Rezo Jorbenadze, Michal Droppa, Wenzhong Zhang, Sarah Mandel, Lisa Habel, Henning Lausberg, Janine Pöss, Tobias Geisler, Oliver Borst, Peter Rosenberger, Christian Schlensak, Meinrad Gawaz, Jürgen Schreieck, Peter Seizer, Harald F Langer
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0205930 (2018)
BACKGROUND:Patients after transcatheter aortic valve replacement (TAVR) and persistent severe mitral regurgitation (MR) are increasingly treated with percutaneous edge-to-edge mitral valve repair (PMVR). The impact of a former TAVR on PMVR procedures
Externí odkaz:
https://doaj.org/article/7b7c063099c64a57a0348d2d15097df4
Autor:
Johannes Patzelt, Miriam Ulrich, Harry Magunia, Reinhard Sauter, Michal Droppa, Rezo Jorbenadze, Annika S. Becker, Tobias Walker, Ralph Stephan von Bardeleben, Christian Grasshoff, Peter Rosenberger, Meinrad Gawaz, Peter Seizer, Harald F. Langer
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 12 (2017)
BackgroundPercutaneous edge‐to‐edge mitral valve repair (PMVR) has become an established treatment option for mitral regurgitation in patients not eligible for surgical repair. Currently, most procedures are performed under general anesthesia (GA
Externí odkaz:
https://doaj.org/article/86ce8d8d312c42fb87c4d44ecb203cbc